Literature DB >> 15239631

One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation.

Ragai R Mitry1, Anil Dhawan, Robin D Hughes, Sanjay Bansal, Sharon Lehec, Claire Terry, Nigel D Heaton, John B Karani, Giorgina Mieli-Vergani, Mohamed Rela.   

Abstract

Hepatocyte transplantation is emerging as a possible treatment for patients with acute liver failure and liver-based metabolic disorders. With the limited availability of donor tissue, it is important to find new sources of liver tissue for isolation of high-quality hepatocytes. Segment IV with or without the caudate lobe was removed during three split-liver procedures. Hepatocytes were isolated from the tissues using a collagenase perfusion technique under strict sterile conditions. The mean number of hepatocytes that were isolated was 5.14 x 10(8) cells with a mean cell viability of 89%. Two of the hepatocyte preparations were used for cell transplantation in a 1-day-old boy with an antenatal diagnosis of a severe urea cycle defect caused by ornithine transcarbamylase deficiency. The six recipients of split-liver grafts demonstrated no complications related to the removal of segment IV. Segment IV with or without the caudate lobe obtained from split-liver procedures is potentially a good source of high-quality hepatocytes for cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15239631     DOI: 10.1097/01.tp.0000122224.98318.19

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  27 in total

1.  Hepatocyte transplantation.

Authors:  Ragai R Mitry; Robin D Hughes; Anil Dhawan
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 2.  Perspectives on whole-organ assembly: moving toward transplantation on demand.

Authors:  Alejandro Soto-Gutierrez; Jason A Wertheim; Harald C Ott; Thomas W Gilbert
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

Review 3.  Cell delivery: from cell transplantation to organ engineering.

Authors:  Alejandro Soto-Gutierrez; Hiroshi Yagi; Basak E Uygun; Nalu Navarro-Alvarez; Korkut Uygun; Naoya Kobayashi; Yong-Guang Yang; Martin L Yarmush
Journal:  Cell Transplant       Date:  2010-06-03       Impact factor: 4.064

Review 4.  Cell-based liver therapies: past, present and future.

Authors:  Valeria Iansante; Anil Chandrashekran; Anil Dhawan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

Review 5.  Hepatocyte transplantation for liver-based metabolic disorders.

Authors:  Anil Dhawan; Ragai R Mitry; Robin D Hughes
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

6.  Hepatocyte Transplantation in Special Populations: Clinical Use in Children.

Authors:  Zahida Khan; Stephen C Strom
Journal:  Methods Mol Biol       Date:  2017

7.  How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?

Authors:  Marco Carbone; Jan Lerut; James Neuberger
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 8.  Stem cells for liver repopulation.

Authors:  Alejandro Soto-Gutierrez; Nalu Navarro-Alvarez; Hiroshi Yagi; Martin L Yarmush
Journal:  Curr Opin Organ Transplant       Date:  2009-12       Impact factor: 2.640

Review 9.  Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives.

Authors:  Philippe-A Lysy; Mustapha Najimi; Xavier Stephenne; Annick Bourgois; Francoise Smets; Etienne-M Sokal
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

Review 10.  A Rational Strategy for the Use of Amniotic Epithelial Stem Cell Therapy for Liver Diseases.

Authors:  Toshio Miki
Journal:  Stem Cells Transl Med       Date:  2016-03-03       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.